HSH155 Antibody

What is HSH155 and what is its role in the splicing machinery?

HSH155 is a core component of the SF3B complex in Saccharomyces cerevisiae, functioning as the yeast ortholog of human SF3B1. The protein contains multiple HEAT repeats that form a crescent-shaped structure critical for branch site recognition during pre-mRNA splicing. HSH155 plays an essential role in the early stages of spliceosome assembly, particularly in the recognition and selection of the branch site adenosine in pre-mRNA substrates . This recognition step is crucial for splicing fidelity and determines which introns are efficiently processed. HSH155 directly interacts with other splicing factors, most notably Prp5p, which functions as an RNA-dependent ATPase during spliceosome assembly . Together, these proteins form part of the quality control mechanism that ensures accurate intron recognition and removal.

The precise positioning of HSH155 within the splicing machinery allows it to discriminate between optimal and suboptimal branch sites. This discrimination capacity makes HSH155 particularly important for understanding how mutations might affect splice site selection in both yeast and human disease contexts . Research has demonstrated that the HEAT motifs of HSH155 form a binding pocket that cradles the branch site adenosine during splicing, suggesting a direct role in nucleotide recognition during this critical process.

How do mutations in HSH155 affect splicing fidelity?

Mutations in the HEAT motifs of HSH155 specifically alter the splicing of suboptimal branch site pre-mRNA substrates, providing important insights into splicing regulation mechanisms . Research has shown that directed screens for HSH155 alleles that improve splicing of branch site mutants yielded mutations remarkably similar to those found in SF3B1 in various human cancers . These mutations typically do not eliminate splicing function entirely but rather alter branch site selection specificity.

The effects of HSH155 mutations are substrate-specific, with certain pre-mRNAs being more sensitive to changes in HSH155 function than others. This substrate specificity appears to be determined by the sequence context surrounding the branch site, particularly the strength of the branch site sequence itself . When HSH155 is mutated, splicing of suboptimal branch sites can be either enhanced or suppressed, depending on the specific mutation and substrate combination. Tang et al. demonstrated that HSH155 mutant alleles phenocopied the effects on sensitive splicing reporters that PRP5 mutants had shown previously, suggesting a mechanistic link between these two proteins in maintaining splicing fidelity .

The mutations that affect splicing fidelity cluster in the HEAT repeat domains that interact with the branch site adenosine and Prp5p, indicating that altering these interactions directly impacts how the spliceosome distinguishes between optimal and suboptimal branch sites . This research provides a mechanistic framework to explain how SF3B1 mutations found in human cancers might lead to altered splicing patterns.

What are the most effective methods for studying HSH155-protein interactions?

Co-immunoprecipitation (Co-IP) has proven particularly effective for studying HSH155's interactions with other splicing factors. Researchers have successfully employed TAP-tagged HSH155 or its binding partners (such as Cus1) in combination with GFP-tagged proteins to investigate direct protein-protein interactions under various experimental conditions . This approach allows for the detection of both stable and transient interactions that may be affected by cellular stressors like methyl methanesulfonate (MMS) .

For studying the interaction between HSH155 and Prp5p specifically, researchers have utilized recombinant protein approaches with purified truncated GST-HSH155 proteins representing a tiled array of the full protein, along with His-tagged Prp5p purified from E. coli . This method allowed for mapping of specific interaction domains between these proteins. Visualizing these interactions can be accomplished through live-cell imaging of fluorescently-tagged HSH155 alongside other tagged splicing factors to observe their co-localization or separation under different conditions .

Yeast two-hybrid assays and proximity ligation assays have also been employed to detect HSH155 interactions, though these techniques may identify indirect interactions as well. For stronger validation of direct interactions, in vitro binding assays using purified recombinant proteins have been particularly informative . When designing interaction studies, it's critical to consider whether treatments like MMS might cause complex disassembly before protein aggregation, which could affect interpretation of results .

How can researchers create and validate humanized HSH155 models for splicing inhibitor studies?

Creating humanized HSH155 models requires careful alignment of HEAT repeats from human SF3B1 and yeast HSH155 to identify residues that differ, followed by strategic substitution of human residues into the yeast protein . Researchers have successfully employed CRISPR/Cas9 genome editing to cleave HSH155 in strains deleted for drug exporter genes (PDR5, SNQ2, and YOR1), while providing a homologous repair fragment containing the desired humanized sequence .

The most successful humanized HSH155 model (HSH155-ds) involved substituting 14 amino acids in the Hsh155 protein with corresponding human SF3B1 residues to create a binding pocket for splicing inhibitors like Pladienolide B (Plad-B) and Herboxidiene (HB) . When designing humanized constructs, it's important to consider that complete humanization of certain regions (such as HRs 15-16) may cause temperature sensitivity, while partial humanization may maintain normal growth while still conferring inhibitor sensitivity .

Validation of humanized HSH155 models should include:

• Growth assays at different temperatures to assess potential temperature sensitivity

• In vitro splicing assays with extracts from humanized strains to test inhibitor sensitivity

• Splicing complex formation assays to determine the stage at which inhibition occurs

• In vivo fluorescent reporter systems that express fluorescent proteins when splicing is inhibited

The successful humanized HSH155-ds strain showed IC50 values of approximately 47-74 nM for inhibition by herboxidiene, comparable to inhibition levels in human systems, confirming the creation of an effective drug binding pocket that maintains normal splicing function in the absence of inhibitors .

How does cellular stress affect HSH155 localization and function?

Under genotoxic stress conditions such as alkylation damage from MMS treatment, HSH155 exhibits a dramatic change in localization, disassembling from its splicing complex partners and relocating to protein quality control (PQC) aggregates . This relocalization occurs in a biphasic manner, with HSH155 first appearing in intranuclear quality control (INQ) sites and subsequently in cytoplasmic aggregates . The timing and extent of this relocalization depend on both the type and intensity of the cellular stress.

Interestingly, the relocalization of HSH155 to aggregates is selective rather than a general response of all splicing factors. For example, while HSH155 dissociates from its binding partner HSH49 after MMS treatment and localizes to aggregates, other spliceosomal proteins may not exhibit the same behavior . This selective aggregation suggests a specific regulatory mechanism rather than a general aggregation of all nuclear proteins during stress.

What techniques are most effective for tracking HSH155 localization changes during stress response?

Live-cell imaging of GFP-tagged HSH155 has proven to be the most effective technique for tracking its dynamic relocalization during stress response . This approach allows for real-time observation of HSH155 movement to INQ and cytoplasmic aggregates under various stress conditions. For optimal results, researchers should employ high-resolution fluorescence microscopy with appropriate nuclear markers (such as Hta2-mCherry) to distinguish between nuclear and cytoplasmic localization .

Tandem fluorescent timer (tFT) experiments, which involve tagging HSH155 with fluorescent proteins that mature at different rates, have been particularly valuable for determining the relative age of HSH155 proteins in different aggregate populations . This technique revealed that younger pools of HSH155 tend to accumulate in cytoplasmic aggregates compared to the INQ, suggesting independent aggregation pathways rather than sequential transport between compartments .

For quantitative analysis of HSH155 localization, researchers have successfully employed:

• Cell counting to determine the percentage of cells showing HSH155 aggregates

• Measurement of fluorescence intensity in different cellular compartments

• Colocalization studies with known markers of INQ (such as Cmr1) and cytoplasmic aggregates

• Time-lapse imaging to track the kinetics of aggregate formation and dissolution

When designing localization studies, it's important to synchronize cells (using α-factor for G1/S arrest or nocodazole for G2/M arrest) before stress treatment to control for cell cycle effects on protein localization . Additionally, washing out the stressor and tracking recovery provides valuable insights into the reversibility and functional significance of HSH155 relocalization.

How do disease-associated mutations in human SF3B1 compare to experimental mutations in yeast HSH155?

Disease-associated mutations in human SF3B1, particularly those found in various cancers, have striking parallels to experimental mutations in yeast HSH155 that alter splicing fidelity . Research has shown that many cancer-associated SF3B1 mutations cluster in the HEAT repeat domains, similar to the mutations identified in directed screens for HSH155 alleles that improve splicing of branch site mutant reporters in yeast . This parallelism provides a valuable experimental system for understanding the mechanistic consequences of disease mutations.

The effects of both disease-associated SF3B1 mutations and experimental HSH155 mutations appear to be mediated through altered branch site recognition and selection. Tang et al. demonstrated that HSH155 mutant alleles specifically changed splicing of suboptimal branch site pre-mRNA substrates, providing a framework to explain how SF3B1 mutations in human disease might lead to altered splicing patterns . These mutations typically don't eliminate splicing function entirely but rather change the specificity of branch site selection, potentially leading to the use of cryptic splice sites or altered splicing efficiency of specific transcripts.

Comparative studies between yeast HSH155 and human SF3B1 are particularly informative because the functional domains and key interaction surfaces are highly conserved between these orthologs. The successful creation of "humanized" HSH155 strains, where key residues in the yeast protein are replaced with their human counterparts, further demonstrates this conservation and provides valuable tools for studying SF3B1-targeted therapeutics in a yeast model system .

What role does HSH155 play in the broader context of cellular quality control systems?

HSH155 serves as an important link between RNA splicing and protein quality control systems in the cell. Under stress conditions, HSH155 is selectively targeted to protein quality control (PQC) aggregates, including the intranuclear quality control compartment (INQ) and cytoplasmic aggregates . This relocalization is regulated by molecular chaperones and the Cdc48/VCP ATPase, which plays an essential role in protein quality control and complex disassembly .

Research has shown that Cdc48 physically associates with HSH155 and regulates its assembly with partner proteins . In Cdc48 mutants, HSH155 shows spontaneous distribution to INQ aggregates where it is stabilized, suggesting that Cdc48 normally prevents inappropriate aggregation of HSH155 . This regulation appears to be part of a broader role for Cdc48 in maintaining the stability of splicing subcomplexes under normal conditions and facilitating their reorganization during stress .

The selective sequestration of HSH155 in quality control compartments during stress has functional consequences for splicing, leading to intron retention in specific transcripts, particularly ribosomal protein genes . This process appears to be adaptive, as cells with proper HSH155 sequestration show more rapid recovery from stress . The selective nature of HSH155 aggregation—compared to other splicing factors—suggests that this process represents a regulatory mechanism rather than simple protein damage or misfolding.

The following table summarizes the key quality control factors that interact with HSH155:

How can splicing inhibitors be used to probe HSH155 function in experimental systems?

Splicing inhibitors targeting the SF3B complex provide powerful tools for studying HSH155 function in both yeast and human systems. Researchers have successfully created humanized HSH155 strains sensitive to inhibitors like Pladienolide B (Plad-B) and Herboxidiene (HB), opening new avenues for experimental manipulation of splicing . These inhibitors bind to the pocket surrounding the branch site adenosine binding region, preventing proper spliceosome assembly at or near the prespliceosome or A-complex formation stage .

When designing experiments with splicing inhibitors, researchers should consider several methodological approaches:

• In vitro splicing assays with cell extracts from wild-type or humanized HSH155 strains to determine inhibitor sensitivity and IC50 values

• Splicing complex formation assays to identify the precise stage at which inhibition occurs

• In vivo fluorescent reporter systems that express fluorescent proteins when splicing is inhibited

• Transcriptome-wide analysis to identify intron-specific effects of inhibition

The humanized HSH155-ds strain has proven particularly valuable, as it shows inhibitor sensitivity comparable to human systems while maintaining normal splicing function in the absence of inhibitors . One advantage of using yeast systems with humanized HSH155 is the ability to study inhibitor effects without the confounding variables present in cancer cell lines, which may have multiple mutations affecting splicing regulation.

For optimal results, researchers should use strains with deleted drug exporter genes (PDR5, SNQ2, and YOR1) to prevent active efflux of inhibitors from cells . Additionally, comparing wild-type and humanized HSH155 strains treated with the same inhibitor concentrations provides valuable internal controls for inhibitor specificity.

What emerging technologies show promise for studying HSH155 dynamics and interactions?

Several cutting-edge technologies show particular promise for advancing our understanding of HSH155 dynamics and interactions:

Cryo-electron microscopy (cryo-EM) has revolutionized our ability to visualize splicing complexes at near-atomic resolution, providing unprecedented insights into the structural basis of HSH155 function within the spliceosome. This technique allows visualization of HSH155/SF3B1 in different functional states and in complex with splicing inhibitors, offering direct structural insights into mechanism.

Single-molecule fluorescence resonance energy transfer (smFRET) techniques hold tremendous potential for studying the dynamic rearrangements of HSH155 during spliceosome assembly and catalysis. By labeling HSH155 and its interaction partners with fluorescent dyes, researchers can observe conformational changes and protein-protein interactions in real-time at the single-molecule level.

Proximity labeling approaches such as BioID or APEX2 could enable systematic identification of HSH155 interaction partners under different conditions. These techniques involve fusing HSH155 to an enzyme that biotinylates nearby proteins, allowing for subsequent purification and identification of the proximal proteome under normal versus stress conditions.

For studying the dynamic localization of HSH155 during stress, super-resolution microscopy techniques such as structured illumination microscopy (SIM) or stochastic optical reconstruction microscopy (STORM) would provide superior spatial resolution compared to conventional fluorescence microscopy. These approaches could reveal previously unobservable details about HSH155 aggregate structure and composition.

Integrative approaches that combine structural, biochemical, and cellular techniques will likely yield the most comprehensive understanding of HSH155 function in splicing regulation and stress response. The development of cell-based assays that can rapidly report on HSH155 function in response to genetic or pharmacological perturbations will be particularly valuable for high-throughput studies.